Stocktoria
Inhibikase Therapeutics, Inc. IKT
Inhibikase Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 2,928,077 | $4.9M | 2.22% |
| CITADEL ADVISORS LLC | 1,102,585 | $1.9M | 0.84% |
| TWO SIGMA INVESTMENTS, LP | 847,611 | $1.4M | 0.64% |
| AQR CAPITAL MANAGEMENT LLC | 172,013 | $288,982 | 0.13% |
| Point72 Asset Management, L.P. | 40,383 | $67,843 | 0.03% |
| RENAISSANCE TECHNOLOGIES LLC | 16,500 | $27,720 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.